All Articles

After eight years in stealth, an American 3D printing company is challenging the hype-driven tech world with a simple idea: build a reliable product first.

Johnson & Johnson's massive investment in Jacksonville promises economic growth, but the real story is a strategic pivot to secure the U.S. healthcare supply chain.

A small Canadian firm's breakthrough in water technology could slash energy use in major industries. But can it overcome the hurdles to commercialization?

The collateral management firm appoints a new CPO and promotes key execs, signaling a foundational shift to build autonomous AI-native products.

A new partnership between Argonaut and Ensera aims to untangle complex supply chains for drug-device products, potentially leveling the field for smaller innovators.

A new partnership aims to move beyond static risk models by integrating real-time news sentiment, giving firms a crucial edge in navigating market volatility.

A California company has turned raw dairy biogas into jet fuel, a world-first that promises to tackle aviation's climate crisis and create a new gold rush for farmers.

A bitter proxy fight erupts at Fermi Inc., pitting its founder against the board. At stake is not just the company, but its ambitious AI power grid project.

A class action alleges catastrophic data failures at Canada's tax agency, costing families thousands and exposing a potential billion-dollar liability.

For 20 years, Montreal's Segal Cancer Centre has quietly built a world-class innovation engine. We dissect its unique model where research, care, and funding converge.

LONGi celebrates a massive solar milestone, but with industry margins squeezed, we analyze if its high-efficiency bet can deliver long-term value.

The Shanghai Museum dedicates its entire venue to 3,000 artifacts from Mexico and Peru. This isn't just an exhibition; it's a new model for cultural infrastructure.

Amid rising cyber threats, Toobit launches a security hub with verifiable Proof of Reserves. But does this bet on transparency truly redefine trust?

The graduation of Hemlo Mining to the TSX is more than a financial footnote. It's a story of strategic revitalization for a legendary Canadian gold camp.

China's Atom Therapeutics is advancing a dual-threat pipeline, with novel drugs for gout and a groundbreaking anti-inflammatory aimed at cardiovascular disease.

Amid a frenzied market for drill rigs, Eminent Gold begins a pivotal program in Nevada. It's a story of high-tech exploration and strategic patience.

Skanska's massive Karlstad hospital project promises a high-tech future, but can a building solve deep-seated healthcare system challenges like staff shortages?

A new pact between BioSTL and the UK's NHS is set to make St. Louis a prime U.S. launchpad for health tech, turning global innovation into local impact.

While biopharma braces for Medicare price negotiations, Halozyme claims immunity. Is its tech-licensing model the new blueprint for resilience or just a loophole?

With new drinks, TaylorMade merch, and John Daly, Dunkin's golf campaign is a lesson in modern branding. It's about selling an identity, not just a product.